hotspot -WSS

hotspot

author：leisure time 2025-09-27 19:50:29 - browse：6519

Seng Cheng has been working in gene therapy for nearly as long as gene therapy has been a field. As a young scientist in the early 1990s, he was part of one of three teams racing to develop a gene therapy for cystic fibrosis, a high-profile effort that resulted in national headlines, prestigious publications, and zero patients cured.

So he’s seen the field’s highs and lows. Lately, there have been a lot of both, including at Pfizer, the company Cheng called home until this summer. The pharma brought three potentially powerful gene therapies for muscular dystrophy and hemophilia into late-stage trials but, in January, chose to abandon a large portfolio of early stage candidates that relied on the same technology: adeno-associated viruses, or AAVs, a group of small bugs that scientists spent two decades taming into a gene shipping system.

The move seemed emblematic. Across the industry, AAV companies have been struggling, either shelving programs or stopping work altogether, while investors shuttled money toward new technologies such as CRISPR and its various permutations. Longtime researchers feared promising drugs, particularly for ultra-rare diseases, might get lost in the shuffle.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Trump's false claims about Georgia's 2020 election long debunked

knowledge

WSS

Crowdfunding for medical bills sidesteps core problem, author says

AI for drug discovery: Experts on separating hype from reality

AltruBio raises $225 million to develop ulcerative colitis drug

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

BIO to announce reorganization, senior leaders expected to depart

knowledge

hotspot

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Moonlake's readout produced a cash windfall. Risks remain

Evacuations in place as 3 wildfires burn in eastern Washington state

Moonlake's readout produced a cash windfall. Risks remain

Trump cancels press conference intended to dispute Georgia election interference charges

Psychedelics group wrestles with new pharma identity

Lung cancer is America's deadliest cancer. Yet so few get screened

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Brain technologies pose threats that are all too real, experts warn

knowledge

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

AltruBio raises $225 million to develop ulcerative colitis drug

Primary care doctor shortage won't be solved by free med school tuition

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Evacuations in place as 3 wildfires burn in eastern Washington state

Chemotherapy before breast cancer surgery might fuel metastasis

knowledge

leisure time

entertainment

explore